Company / Revenue
Eloxx Pharmaceuticals, Inc. Revenue History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
-
FY2025
5-year range
$0 / $182.2K
FY2021-FY2025
Trend
-100.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $7,819 to $0 over the past 10 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue decreased 100.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2016 | $182.2K | +2230.6% |
| FY2015 | $7.8K | +0.0% |
| FY2014 | $7.8K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026